Safety and Risk Assessment of No-Prescription Online Semaglutide Purchases
- PMID: 39093567
- PMCID: PMC11297364
- DOI: 10.1001/jamanetworkopen.2024.28280
Safety and Risk Assessment of No-Prescription Online Semaglutide Purchases
Plain language summary
This qualitative study assesses the quality, amount of active ingredient, and characteristics associated with counterfeiting of semaglutide purchased from illegal online pharmacies without a prescription.
Conflict of interest statement
Figures
References
-
- Mackey T, Jarmusch A, Xu Q, et al. . Multifactor quality and safety analysis of antimicrobial drugs sold by online pharmacies that do not require a prescription: multiphase observational, content analysis, and product evaluation study. JMIR Public Health Surveill. 2022;8(12):e41834. doi:10.2196/41834 - DOI - PMC - PubMed
-
- Schiavetti B, Wynendaele E, Melotte V, Van der Elst J, De Spiegeleer B, Ravinetto R. A simplified checklist for the visual inspection of finished pharmaceutical products: a way to empower frontline health workers in the fight against poor-quality medicines. J Pharm Policy Pract. 2020;13:9. doi:10.1186/s40545-020-00211-9 - DOI - PMC - PubMed
-
- FDA Center for Drug Evaluation and Research . Warning letter: www.semaspace.com—MARCS-CMS 665848. October 2, 2023. Accessed July 3, 2024. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-inve...
-
- FDA Center for Drug Evaluation and Research . Warning letter: US Chem Labs—MARCS-CMS 669074. February 7, 2024. Accessed July 3, 2024. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-inve...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources